UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059838
Receipt number R000068431
Scientific Title Effects of Concurrent Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Continuous Deep Breathing/Aerobic Exercise on Pain Inhibition
Date of disclosure of the study information 2025/11/22
Last modified on 2025/11/20 17:31:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Concurrent Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Continuous Deep Breathing/Aerobic Exercise on Pain Inhibition

Acronym

Effects of Concurrent Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Continuous Deep Breathing/Aerobic Exercise on Pain Inhibition

Scientific Title

Effects of Concurrent Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Continuous Deep Breathing/Aerobic Exercise on Pain Inhibition

Scientific Title:Acronym

Effects of Concurrent Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Continuous Deep Breathing/Aerobic Exercise on Pain Inhibition

Region

Japan


Condition

Condition

Chronic pain

Classification by specialty

Psychosomatic Internal Medicine Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Chronic pain is a serious global issue, and traditional treatments have limitations such as the need for specialized guidance and the risk of side effects. Therefore, simple approaches that increase neurotransmitters, such as deep breathing and aerobic exercise, have gained attention. Deep breathing activates the brain via the vagus nerve, but its effects tend to be unstable. In contrast, combining it with transcutaneous auricular vagus nerve stimulation (taVNS) may stabilize vagal activity and enhance pain-relieving effects. Aerobic exercise suppresses pain through endogenous opioids, but individuals with chronic pain may find it difficult to continue due to autonomic dysfunction and other factors. However, combining aerobic exercise with taVNS may help maintain autonomic and cognitive function. The aim of this study is to compensate for the limitations of deep breathing and exercise and to examine whether combining them with taVNS can produce stable analgesic effects.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

pressure pain threshold at rest

Key secondary outcomes

heart rate variability, salivary amylase concentration, state-trait anxiety inventory, respiratory rate at rest, accuracy and response time in the Stroop test


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Participants will perform deep breathing for 10 minutes per day for 14 days while receiving transcutaneous auricular vagus nerve stimulation on the cymba conchae (continuous deep breathing and active taVNS).

Interventions/Control_2

Participants will perform deep breathing for 10 minutes per day for 14 days while receiving transcutaneous auricular vagus nerve stimulation on the earlobe (continuous deep breathing and sham taVNS).

Interventions/Control_3

Participants will perform deep breathing for 10 minutes once a week for 3 weeks while receiving transcutaneous auricular vagus nerve stimulation on the cymba conchae (weekly deep breathing and active taVNS).

Interventions/Control_4

Participants will perform deep breathing for 10 minutes once a week for 3 weeks while receiving transcutaneous auricular vagus nerve stimulation on the earlobe (weekly deep breathing and sham taVNS).

Interventions/Control_5

Combination of aerobic exercise and transcutaneous auricular vagus nerve stimulation on the cymba conchae (active taVNS).

Interventions/Control_6

Combination of aerobic exercise and transcutaneous auricular vagus nerve stimulation on the earlobe (sham taVNS).

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy undergraduate or graduate students

Key exclusion criteria

Individuals with a personal or family history of epilepsy, anxiety disorders, or cardiovascular disease, Pregnant individuals, Individuals experiencing pain, Individuals who exercise three or more times per week

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Katsuaki Yamanami, Hirotake Yokota
Middle name Katsuaki, Hirotake
Last name Yamanami, Yokota

Organization

Graduate School Niigata University of Health and Welfare

Division name

Graduate School of Medical and Welfare Studies

Zip code

950-3198

Address

1398 Shimami-cho, Kita-ku, Niigata City, Niigata

TEL

025-257-4500

Email

hpm24005@nuhw.ac.jp


Public contact

Name of contact person

1st name Katsuaki Yamanami
Middle name Katsuaki
Last name Yamanami

Organization

Graduate School Niigata University of Health and Welfare

Division name

Graduate School of Medical and Welfare Studies

Zip code

950-3198

Address

1398 Shimami-cho, Kita-ku, Niigata City, Niigata

TEL

090-4135-3635

Homepage URL


Email

hpm24005@nuhw.ac.jp


Sponsor or person

Institute

Graduate School Niigata University of Health and Welfare, Graduate School of Medical and Welfare Studies

Institute

Department

Personal name



Funding Source

Organization

Graduate School Niigata University of Health and Welfare, Graduate School of Medical and Welfare Studies

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University of Health and Welfare

Address

1398 Shimami-cho, Kita-ku, Niigata City, Niigata

Tel

025-257-4500

Email

hpm24005@nuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 15 Day

Date of IRB


Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 11 Month 20 Day

Last modified on

2025 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068431